Light Switch Bio
PrivateLast Round
Grant
May 1, 2025
Total Funding Raised
$450,000
Company Overview
Light Switch Bio operates in Healthcare & Life Sciences and is based in Richmond, Virginia. Its latest recorded funding round was a Grant round in May 2025.
Light Switch Bio is a biotechnology company that develops photoactivated chemotherapies and laser-targeted drug delivery systems to reduce toxicity and improve drug efficacy.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Data as a Service, Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Light Switch Bio Comparables
Compare Light Switch Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Covalt Bio | 89% | |
| LightOx Ltd | 82% | |
| GenLumina | 79% |
For institutional investors. Book with your work email.
Light Switch Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | May 1, 2025 | ||||
| Early Funding | Jan 6, 2025 | ||||
| Accelerator | Aug 28, 2024 | ||||
| Grant | Aug 3, 2023 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Light Switch Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Cancer Institute | Grant |
| Activation Capital | Accelerator |
| gener8tor | Accelerator |
| Virginia Innovation Partnership Corporation | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 1, 2025
$50K grant received from Virginia Innovation Partnership Corporation.
- Jan 6, 2025
Raised $5M in early funding.
For institutional investors. Book with your work email.
Light Switch Bio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Light Switch Bio's valuation, stock price, and market status.
Is Light Switch Bio a public or private company?
Light Switch Bio is a private company.
What is the current stock price of Light Switch Bio?
Light Switch Bio is a private company, so its shares have no public market price. Caplight tracks Light Switch Bio's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Light Switch Bio worth (valuation)?
Valuation information for Light Switch Bio is not publicly available.
Can I buy Light Switch Bio stock?
Light Switch Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Light Switch Bio's last funding round?
Light Switch Bio's most recent funding round was Grant on May 1, 2025.
Who are the main investors in Light Switch Bio?
Key investors in Light Switch Bio include National Cancer Institute, Activation Capital, gener8tor, Virginia Innovation Partnership Corporation.
Will Light Switch Bio IPO soon?
No public IPO plans have been announced for Light Switch Bio.
How can I track Light Switch Bio secondary market activity?
Caplight tracks bids, offers, and trades in Light Switch Bio's shares on secondary markets.